Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
J Biol Chem. 2013 May 3;288(18):12753-65. doi: 10.1074/jbc.M112.421891. Epub 2013 Mar 14.
Uncontrolled activation of the alternative complement pathway (AP) is thought to be associated with age-related macular degeneration. Previously, we have shown that in retinal pigmented epithelial (RPE) monolayers, oxidative stress reduced complement inhibition on the cell surface, resulting in sublytic complement activation and loss of transepithelial resistance (TER), but the potential ligand and pathway involved are unknown. ARPE-19 cells were grown as monolayers on transwell plates, and sublytic complement activation was induced with H2O2 and normal human serum. TER deteriorated rapidly in H2O2-exposed monolayers upon adding normal human serum. Although the effect required AP activation, AP was not sufficient, because elimination of MASP, but not C1q, prevented TER reduction. Reconstitution experiments to unravel essential components of the lectin pathway (LP) showed that both ficolin and mannan-binding lectin can activate the LP through natural IgM antibodies (IgM-C2) that recognize phospholipid cell surface modifications on oxidatively stressed RPE cells. The same epitopes were found on human primary embryonic RPE monolayers. Likewise, mouse laser-induced choroidal neovascularization, an injury that involves LP activation, could be increased in antibody-deficient rag1(-/-) mice using the phospholipid-specific IgM-C2. In summary, using a combination of depletion and reconstitution strategies, we have shown that the LP is required to initiate the complement cascade following natural antibody recognition of neoepitopes, which is then further amplified by the AP. LP activation is triggered by IgM bound to phospholipids. Taken together, we have defined novel mechanisms of complement activation in oxidatively stressed RPE, linking molecular events involved in age-related macular degeneration, including the presence of natural antibodies and neoepitopes.
补体替代途径(AP)的失控激活被认为与年龄相关性黄斑变性有关。以前,我们已经表明,在视网膜色素上皮(RPE)单层细胞中,氧化应激会降低细胞表面的补体抑制作用,导致亚致死性补体激活和跨上皮电阻(TER)丧失,但潜在的配体和途径尚不清楚。ARPE-19 细胞在 Transwell 板上培养为单层细胞,并使用 H2O2 和正常人血清诱导亚致死性补体激活。在加入正常人血清后,H2O2 暴露的单层细胞中的 TER 迅速恶化。尽管该效应需要 AP 激活,但 AP 是不够的,因为消除 MASP,但不是 C1q,可防止 TER 降低。为了解析凝集素途径(LP)的基本成分而进行的重建实验表明,ficolin 和甘露聚糖结合凝集素都可以通过天然 IgM 抗体(IgM-C2)激活 LP,该抗体识别氧化应激 RPE 细胞表面的磷脂细胞表面修饰。在人原代胚胎 RPE 单层细胞上也发现了相同的表位。同样,在缺乏抗体的 rag1(-/-) 小鼠中,通过针对磷脂的特异性 IgM-C2,可增加涉及 LP 激活的激光诱导脉络膜新生血管形成。总之,使用耗竭和重建策略的组合,我们已经表明,LP 需要在天然抗体识别新表位后引发补体级联反应,然后由 AP 进一步放大。LP 激活是由与磷脂结合的 IgM 触发的。综上所述,我们已经确定了氧化应激 RPE 中补体激活的新机制,将与年龄相关性黄斑变性相关的分子事件联系起来,包括天然抗体和新表位的存在。